Cite
Rozalski R, Gackowski D, Skalska-Bugala A, et al. The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response. Sci Rep. 2021;11(1):21345doi: 10.1038/s41598-021-00880-9.
Rozalski, R., Gackowski, D., Skalska-Bugala, A., Starczak, M., Siomek-Gorecka, A., Zarakowska, E., Modrzejewska, M., Dziaman, T., Szpila, A., Linowiecka, K., Guz, J., Szpotan, J., Gawronski, M., Labejszo, A., Gackowska, L., Foksinski, M., Olinska, E., Wasilow, A., Koltan, A., Styczynski, J., & Olinski, R. (2021). The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response. Scientific reports, 11(1), 21345. https://doi.org/10.1038/s41598-021-00880-9
Rozalski, Rafal, et al. "The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response." Scientific reports vol. 11,1 (2021): 21345. doi: https://doi.org/10.1038/s41598-021-00880-9
Rozalski R, Gackowski D, Skalska-Bugala A, Starczak M, Siomek-Gorecka A, Zarakowska E, Modrzejewska M, Dziaman T, Szpila A, Linowiecka K, Guz J, Szpotan J, Gawronski M, Labejszo A, Gackowska L, Foksinski M, Olinska E, Wasilow A, Koltan A, Styczynski J, Olinski R. The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response. Sci Rep. 2021 Nov 01;11(1):21345. doi: 10.1038/s41598-021-00880-9. PMID: 34725426; PMCID: PMC8560782.
Copy
Download .nbib